FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1860-1866 June 26, 1997 Number 26 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Idiopathic giant-cell myocarditis is a rare and frequently fatal disorder. We used a multicenter data base to define the natural history of giant-cell myocarditis and the effect of treatment.

Methods We identified 63 patients with idiopathic giant-cell myocarditis through journal announcements and direct mailings to cardiovascular centers worldwide.

Results The patients consisted of 33 men and 30 women with an average age of 42.6 years; 88 percent were white, 5 percent were black, 5 percent were Southeast Asian or Indian, and 2 percent were Middle Eastern. Most presented with congestive heart failure (47 patients, or 75 percent), ventricular arrhythmia (9 patients, or 14 percent), or heart block (3 patients, or 5 percent), although in some cases the initial symptoms resembled those of acute myocardial infarction (4 patients). Nineteen percent had associated autoimmune disorders. The rate of survival was worse than among 111 patients with lymphocytic myocarditis in the Myocarditis Treatment Trial (P<0.001); among our patients, the rate of death or cardiac transplantation was 89 percent, and median survival was only 5.5 months from the onset of symptoms. The 22 patients treated with corticosteroids and cyclosporine, azathioprine, or both therapies survived for an average of 12.3 months, as compared with an average of 3.0 months for the 30 patients who received no immunosuppressive therapy (P = 0.001). Of the 34 patients who underwent heart transplantation, 9 (26 percent) had a giant-cell infiltrate in the transplanted heart and 1 died of recurrent giant-cell myocarditis.

Conclusions Giant-cell myocarditis is a disease of relatively young, predominantly healthy adults. Patients usually die of heart failure and ventricular arrhythmia unless cardiac transplantation is performed. Despite the possibility of fatal disease recurrence, transplantation is the treatment of choice for most patients.

Source Information

From the Department of Medicine, University of California at San Diego Medical Center, San Diego (L.T.C., R.S.), and the Department of Pathology, Stanford University Hospital, Stanford, Calif. (G.J.B.).

Address reprint requests to Dr. Cooper at the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905 (e-mail: cooper.leslie{at}mayo.edu).

Full Text of this Article

This article has been cited by other articles:

• HooKim, K., deRoux, S., Igbokwe, A., Stanek, A., Koo, J., Hsu, J., Pincus, M. R., Bluth, M. H. (2008). IgG Anti-Cardiomyocyte Antibodies in Giant Cell Myocarditis. Annals of Clinical & Laboratory Science 38: 83-87 [Abstract] [Full Text]  
• Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., Virmani, R. (2007). The role of endomyocardial biopsy in the management of cardiovascular disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 28: 3076-3093 [Full Text]  
• Sabatine, M. S., Poh, K.-K., Mega, J. L., Shepard, J.-A. O., Stone, J. R., Frosch, M. P. (2007). Case 36-2007 -- A 31-Year-Old Woman with Rash, Fever, and Hypotension. NEJM 357: 2167-2178 [Full Text]  
• Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., Virmani, R. (2007). The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 50: 1914-1931 [Full Text]  
• Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., Virmani, R., Endorsed by the Heart Failure Society of America a, (2007). The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116: 2216-2233 [Full Text]  
• Binymin, K. A. (2007). Comment on: Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology (Oxford) 46: 1741-1742 [Full Text]  
• Caforio, A. L.P., Calabrese, F., Angelini, A., Tona, F., Vinci, A., Bottaro, S., Ramondo, A., Carturan, E., Iliceto, S., Thiene, G., Daliento, L. (2007). A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28: 1326-1333 [Abstract] [Full Text]  
• Lewis, G. D., Holmes, C. B., Holmvang, G., Butterton, J. R. (2007). Case 8-2007 -- A 48-Year-Old Man with Chest Pain Followed by Cardiac Arrest. NEJM 356: 1153-1162 [Full Text]  
• Graner, M, Lommi, J, Kupari, M, Raisanen-Sokolowski, A, Toivonen, L (2007). Multiple forms of sustained monomorphic ventricular tachycardia as common presentation in giant-cell myocarditis. Heart 93: 119-121 [Full Text]  
• Le Guyader, A., Rolle, F., Karoutsos, S., Cornu, E. (2006). Acute myocarditis supported by extracorporeal membrane oxygenation successfully bridged to transplantation: a giant cell myocarditis. ICVTS 5: 782-784 [Abstract] [Full Text]  
• Cunningham, M. W. (2006). T Regulatory Cells: Sentinels Against Autoimmune Heart Disease. Circ. Res. 99: 1024-1026 [Full Text]  
• Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-e346 [Full Text]  
• Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 746-837 [Full Text]  
• Murashita, T., Sugiki, T., Tachibana, T., Kunihara, T., Sugiki, H. (2006). A case of giant cell myocarditis: Bridge to recovery by long-term mechanical circulatory support without immunosuppressive therapy.. J. Thorac. Cardiovasc. Surg. 132: 432-433 [Full Text]  
• Schenk, S., Arusoglu, L., Morshuis, M., Minami, K., Sarnowski, P., Koerfer, R., El-Banayosy, A. (2006). Triple Bridge-to-Transplant in a Case of Giant Cell Myocarditis Complicated by Human Leukocyte Antigen Sensitization and Heparin-Induced Thrombocytopenia Type II.. Ann. Thorac. Surg. 81: 1107-1109 [Abstract] [Full Text]  
• Magnani, J. W., Dec, G. W. (2006). Myocarditis: Current Trends in Diagnosis and Treatment. Circulation 113: 876-890 [Full Text]  
• Joudinaud, T. M., Fadel, E., Thomas-de-Montpreville, V., Mussot, S., Flecher, E. M., Dartevelle, P. G. (2006). Fatal giant cell myocarditis after thymoma resection in myasthenia gravis. J. Thorac. Cardiovasc. Surg. 131: 494-495 [Full Text]  
• Baughman, K. L. (2006). Diagnosis of Myocarditis: Death of Dallas Criteria. Circulation 113: 593-595 [Full Text]  
• Chimenti, C., Pieroni, M., Russo, A., Sale, P., Russo, M. A., Maseri, A., Frustaci, A. (2005). Laser Microdissection in Clinical Cardiovascular Research. Chest 128: 2876-2881 [Abstract] [Full Text]  
• Futamatsu, H., Suzuki, J.-i., Mizuno, S., Koga, N., Adachi, S., Kosuge, H., Maejima, Y., Hirao, K., Nakamura, T., Isobe, M. (2005). Hepatocyte Growth Factor Ameliorates the Progression of Experimental Autoimmune Myocarditis: A Potential Role for Induction of T Helper 2 Cytokines. Circ. Res. 96: 823-830 [Abstract] [Full Text]  
• Chung, L, Berry, G J, Chakravarty, E F (2005). Giant cell myocarditis: a rare cardiovascular manifestation in a patient with systemic lupus erythematosus. Lupus 14: 166-169 [Abstract]  
• Burch, M (2004). Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence. Heart 90: 1103-1104 [Full Text]  
• Stoica, S. C., Goddard, M., Tsui, S., Dunning, J., McNeil, K., Parameshwar, J., Large, S. R. (2003). Ventricular assist surprise: giant cell myocarditis or sarcoidosis?. J. Thorac. Cardiovasc. Surg. 126: 2072-2074 [Full Text]  
• Okura, Y., Dec, G. W., Hare, J. M., Kodama, M., Berry, G. J., Tazelaar, H. D., Bailey, K. R., Cooper, L. T. (2003). A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 41: 322-329 [Abstract] [Full Text]  
• Afanasyeva, M., Rose, N.R. (2002). Immune mediators in inflammatory heart disease: insights from a mouse model. Eur Heart J Suppl 4: I31-I36 [Abstract]  
• Frustaci, A., Pieroni, M., Chimenti, C. (2002). Immunosuppressive therapy in inflammatory cardiomyopathy. Eur Heart J Suppl 4: I69-I72 [Abstract]  
• Kwok, O.-H., Chau, E. M. C., Wang, E. P., Chow, W.-H. (2002). Coronary Artery Disease Obscuring Giant Cell Myocarditis: A Case Report. ANGIOLOGY 53: 599-603 [Abstract]  
• Burch, M. (2002). Heart failure in the young. Heart 88: 198-202 [Full Text]  
• Frustaci, A., Cuoco, L., Chimenti, C., Pieroni, M., Fioravanti, G., Gentiloni, N., Maseri, A., Gasbarrini, G. (2002). Celiac Disease Associated With Autoimmune Myocarditis. Circulation 105: 2611-2618 [Abstract] [Full Text]  
• Hajjar, R. J., Kradin, R. L. (2002). Case 17-2002 - A 55-Year-Old Man with Second-Degree Atrioventricular Block and Chest Pain. NEJM 346: 1732-1738 [Full Text]  
• Oomman, A., Ramachandran, P., Rao, P. V., Girinath, M. R. (2001). Dor's endoaneurysmorrhaphy in severe heart failure due to giant cell myocarditis. Ann. Thorac. Surg. 71: 2036-2038 [Abstract] [Full Text]  
• Acker, M. A. (2001). Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann. Thorac. Surg. 71 : S73-S76 [Abstract] [Full Text]  
• Hare, J.M., Baughman, K.L. (2001). Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification. Eur Heart J 22: 269-270  
• Feldman, A. M., McNamara, D. (2000). Myocarditis. NEJM 343: 1388-1398 [Full Text]  
• Stevenson, W. G., Aretz, H. T. (2000). Case 20-2000- A 61-Year-Old Man with a Wide-Complex Tachycardia. NEJM 342: 1979-1987 [Full Text]  
• Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., Kasper, E. K. (2000). Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy. NEJM 342: 1077-1084 [Abstract] [Full Text]  
• Davies, M J (2000). CARDIOMYOPATHY: The cardiomyopathies: an overview. Heart 83: 469-474 [Full Text]  
• Karliner, J. S. (2000). Fulminant Myocarditis. NEJM 342: 734-735 [Full Text]  
• Garg, A., Shiau, J., Guyatt, G. (1998). The Ineffectiveness of Immunosuppressive Therapy in Lymphocytic Myocarditis: An Overview. ANN INTERN MED 129: 317-322 [Abstract] [Full Text]  
• Levy, N. T., Olson, L. J., Weyand, C., Brack, A., Tazelaar, H. D., Edwards, W. D., Hammill, S. C. (1998). Histologic and Cytokine Response to Immunosuppression in Giant-Cell Myocarditis. ANN INTERN MED 128: 648-650 [Full Text]  
• Shioji, K., Kishimoto, C., Sasayama, S. (2001). Fc Receptor-Mediated Inhibitory Effect of Immunoglobulin Therapy on Autoimmune Giant Cell Myocarditis: Concomitant Suppression of the Expression of Dendritic Cells. Circ. Res. 89: 540-546 [Abstract] [Full Text]  
• Yokoseki, O., Suzuki, J.-i., Kitabayashi, H., Watanabe, N., Wada, Y., Aoki, M., Morishita, R., Kaneda, Y., Ogihara, T., Futamatsu, H., Kobayashi, Y., Isobe, M. (2001). cis Element Decoy Against Nuclear Factor-{kappa}B Attenuates Development of Experimental Autoimmune Myocarditis in Rats. Circ. Res. 89: 899-906 [Abstract] [Full Text]